BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moroni G, Castellani M, Balzani A, Dore R, Bonelli N, Longhi S, Martinelli I, Messa P, Gerundini P. The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis. Eur J Nucl Med Mol Imaging 2012;39:1635-42. [PMID: 22801728 DOI: 10.1007/s00259-012-2144-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Si M, Zhang K, Li J, He H, Yao Y, Han J, Qiao J. Idiopathic retroperitoneal fibrosis with endometrial cancer: a case report and literature review. BMC Womens Health 2022;22:399. [PMID: 36183056 DOI: 10.1186/s12905-022-01968-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Brandt AS, Goedde D, Kamper L, Haage P, Störkel S, Roth S. Retroperitoneale Fibrose (Morbus Ormond). Die Urologie 2022. [DOI: 10.1007/978-3-642-41168-7_112-2] [Reference Citation Analysis]
3 Dondi F, Albano D, Giubbini R, Bertagna F. PET in idiopathic retroperitoneal fibrosis. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00059-4] [Reference Citation Analysis]
4 Casali M, Lauri C, Altini C, Bertagna F, Cassarino G, Cistaro A, Erba AP, Ferrari C, Mainolfi CG, Palucci A, Prandini N, Baldari S, Bartoli F, Bartolomei M, D'Antonio A, Dondi F, Gandolfo P, Giordano A, Laudicella R, Massollo M, Nieri A, Piccardo A, Vendramin L, Muratore F, Lavelli V, Albano D, Burroni L, Cuocolo A, Evangelista L, Lazzeri E, Quartuccio N, Rossi B, Rubini G, Sollini M, Versari A, Signore A. State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Transl Imaging 2021;9:299-339. [PMID: 34277510 DOI: 10.1007/s40336-021-00445-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
5 Fenaroli P, Maritati F, Vaglio A. Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis. Curr Rheumatol Rep 2021;23:18. [PMID: 33569638 DOI: 10.1007/s11926-020-00966-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
6 Shaikh S. PET-CT in Urological Infections and Inflammations. PET-CT in Infection and Inflammation 2021. [DOI: 10.1007/978-981-15-9801-2_17] [Reference Citation Analysis]
7 Raglianti V, Rossi GM, Vaglio A. Idiopathic retroperitoneal fibrosis: an update for nephrologists. Nephrol Dial Transplant 2020:gfaa083. [PMID: 33005943 DOI: 10.1093/ndt/gfaa083] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
8 Le Joncour A, Saadoun D, Cacoub P. La fibrose rétropéritonéale idiopathique. Rev Med Interne 2020;41:822-8. [PMID: 32727694 DOI: 10.1016/j.revmed.2020.06.013] [Reference Citation Analysis]
9 Raffiotta F, da Silva Escoli R, Quaglini S, Rognoni C, Sacchi L, Binda V, Messa P, Moroni G. Idiopathic Retroperitoneal Fibrosis: Long-term Risk and Predictors of Relapse. Am J Kidney Dis 2019;74:742-50. [PMID: 31204195 DOI: 10.1053/j.ajkd.2019.04.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
10 Pérez-Sanz MT, Cervilla-Muñoz E, Alonso-Muñoz J, Marcelo-Ayala A, Pulfer MD, Galeano-Valle F. Retroperitoneal fibrosis associated with orbital pseudotumor without evidence of IgG4: A case report with review of literature. Intractable Rare Dis Res 2019;8:29-35. [PMID: 30881855 DOI: 10.5582/irdr.2018.01075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Morin G, Mageau A, Benali K, Bertinchamp R, Piekarski E, Raimbourg Q, Alexandra JF, Goulenok T, van Gysel D, Papo T, Sacre K. Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse. Eur J Intern Med 2019;62:67-71. [PMID: 30711361 DOI: 10.1016/j.ejim.2019.01.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Mzabi A, Kéchrid N, Alaya Z, Rezgui A, Ben Fredj F, Bouajina E, Laouani C. [Retroperitoneal fibrosis in adults: Diagnostic approach based on a retrospective multicenter study on 32 cases]. Prog Urol 2019;29:76-85. [PMID: 30579757 DOI: 10.1016/j.purol.2018.10.006] [Reference Citation Analysis]
13 Kalisz K, Partovi S. Diffusion-weighted MR in chronic periaortitis, a new technique has entered the clinical arena. Int J Cardiovasc Imaging 2018;34:1787-1788. [DOI: 10.1007/s10554-018-1458-2] [Reference Citation Analysis]
14 Kamper L, Dreger NM, Brandt AS, Pöppel T, Abanador-kamper N, Roth S, Haage P. Diffusion-weighted MRI and PET–CT in the follow up of chronic periaortitis. Int J Cardiovasc Imaging 2018;34:1779-85. [DOI: 10.1007/s10554-018-1395-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Krombach GA. [Diseases of connective tissue in IgG4-associated autoimmune diseases]. Radiologe 2016;56:1061-8. [PMID: 27882402 DOI: 10.1007/s00117-016-0183-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Grozdic Milojevic IT, Milojevic B, Sobic-Saranovic DP, Artiko VM. Impact of hybrid molecular imaging in retroperitoneal fibrosis: a systematic review. Rheumatol Int 2018;38:179-87. [PMID: 28840309 DOI: 10.1007/s00296-017-3798-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
17 Wang Y, Guan Z, Gao D, Luo G, Li K, Zhao Y, Wang X, Zhang J, Jin J, Zhao Z, Yang C, Zhang J, Zhu J, Huang F. The value of 18F-FDG PET/CT in the distinction between retroperitoneal fibrosis and its malignant mimics. Semin Arthritis Rheum 2018;47:593-600. [PMID: 28958769 DOI: 10.1016/j.semarthrit.2017.07.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
18 Krishnan N, Perazella MA. The Role of PET Scanning in the Evaluation of Patients With Kidney Disease. Adv Chronic Kidney Dis 2017;24:154-61. [PMID: 28501078 DOI: 10.1053/j.ackd.2017.01.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
19 Querellou S, Robin P, Abgral R, Devauchelle V, De Moreuil C, Salaun P, Le Roux P, Le Duc-pennec A. Review article: FDG-PET in inflammatory diseases. Médecine Nucléaire 2017;41:3-14. [DOI: 10.1016/j.mednuc.2016.12.001] [Reference Citation Analysis]
20 Nešković M, Đukić N, Rakic A, Radak Đ. Inflammatory abdominal aortic aneurysm and retroperitoneal fibrosis. Medicinska istraživanja 2017;51:1-8. [DOI: 10.5937/medist1701001n] [Reference Citation Analysis]
21 Laroche AS, Bell RZ, Bezzaoucha S, Földes E, Lamarche C, Vallée M. Retroperitoneal fibrosis: retrospective descriptive study on clinical features and management. Res Rep Urol 2016;8:175-9. [PMID: 27822461 DOI: 10.2147/RRU.S115448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
22 Zheng L, Ding X, Liu K, Feng S, Tang B, Li Q, Huang D, Yang S. Molecular imaging of fibrosis using a novel collagen-binding peptide labelled with 99mTc on SPECT/CT. Amino Acids 2017;49:89-101. [PMID: 27633720 DOI: 10.1007/s00726-016-2328-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
23 Fofi C, Prosperi D, Pettorini L, Festuccia F, Pirisino R, Lanni V, Scopinaro F, Punzo G, Menè P. Diagnosis and follow-up of idiopathic retroperitoneal fibrosis: role of 18F-FDG-PET/CT and biochemical parameters in patients with renal involvement. Intern Emerg Med 2016;11:809-16. [DOI: 10.1007/s11739-016-1426-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
24 Ruhlmann V, Poeppel TD, Brandt AS, Grüneisen J, Ruhlmann M, Theysohn JM, Forsting M, Bockisch A, Umutlu L. (18)F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease. Eur J Nucl Med Mol Imaging 2016;43:1646-52. [PMID: 26969347 DOI: 10.1007/s00259-016-3351-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
25 Vaglio A, Maritati F. Idiopathic Retroperitoneal Fibrosis. J Am Soc Nephrol 2016;27:1880-9. [PMID: 26860343 DOI: 10.1681/ASN.2015101110] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 13.8] [Reference Citation Analysis]
26 Brandt AS, Goedde D, Kamper L, Haage P, Störkel S, Roth S. Retroperitoneale Fibrose (Morbus Ormond). Die Urologie 2016. [DOI: 10.1007/978-3-642-39940-4_112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Bier G, Henes J, Eulenbruch C, Xenitidis T, Nikolaou K, Horger M. Perfusion-based assessment of disease activity in untreated and treated patients with aortitis and chronic periaortitis: correlation with CT morphological, clinical and serological data. Br J Radiol 2015;88:20150526. [PMID: 26423599 DOI: 10.1259/bjr.20150526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
28 Kamper L, Haage P, Brandt AS, Piroth W, Abanador-Kamper N, Roth S, Ekamp H. Diffusion-weighted MRI in the follow-up of chronic periaortitis. Br J Radiol 2015;88:20150145. [PMID: 26110205 DOI: 10.1259/bjr.20150145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
29 Brandt AS, Goedde D, Kamper L, Haage P, Störkel S, Roth S. Retroperitoneale Fibrose (Morbus Ormond). Die Urologie 2015. [DOI: 10.1007/978-3-642-41168-7_112-1] [Reference Citation Analysis]
30 Luo Y, Feng R, Li F. FDG PET/CT appearance of tumor thrombus of ovarian vessels masquerading as retroperitoneal fibrosis. Clin Nucl Med 2015;40:501-3. [PMID: 25546209 DOI: 10.1097/RLU.0000000000000655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
31 Zhang J, Chen H, Ma Y, Xiao Y, Niu N, Lin W, Wang X, Liang Z, Zhang F, Li F, Zhang W, Zhu Z. Characterizing IgG4-related disease with ¹⁸F-FDG PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging 2014;41:1624-34. [PMID: 24764034 DOI: 10.1007/s00259-014-2729-3] [Cited by in Crossref: 152] [Cited by in F6Publishing: 168] [Article Influence: 19.0] [Reference Citation Analysis]
32 Gallais Sérézal I, Le Jeune S, Belenfant X, Bakir R, Fain O, Mekinian A, Gambier N, Mouthon L, Steichen O, Blanche P, Mourad JJ, Dhôte R. [Idiopathic retroperitoneal fibrosis: a multicentric retrospective study of 30 French cases and follow-up of the renal function]. Rev Med Interne 2014;35:570-6. [PMID: 24314845 DOI: 10.1016/j.revmed.2013.11.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
33 Lugosi M, Sacré K, Lidove O, Chauveheid M, Brihaye B, Laissy J, Chauchard M, Papo T. Fibrose(s) rétropéritonéale(s) : stratégie diagnostique, pathologies associées et suivi à long terme d’une cohorte française. La Revue de Médecine Interne 2013;34:591-9. [DOI: 10.1016/j.revmed.2013.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
34 Treglia G, Mattoli MV, Bertagna F. Fluorine-18-fluorodeoxyglucose positron emission tomography in assessing retroperitoneal fibrosis: a literature review. Int J Mol Imaging 2012;2012:484052. [PMID: 23050140 DOI: 10.1155/2012/484052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]